ArticleCurrent psychology (New Brunswick, N.J.)2022
The dark triad and depressive symptoms among chinese adolescents: moderated mediation models of age and emotion regulation strategies.
Article in Current psychology (New Brunswick, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 21 citations in OpenAlex.
- The Longitudinal Relationship Between Dark Triad Traits and Moral Disengagement in Adolescents: A Cross-Lagged Panel Network Analysis.Behavioral sciences (Basel, Switzerland) · 2026Article
- Psychological Adjustment and Dark Triad Traits in Adolescents Living in Residential Care: A Comparative Study Between Boys and Girls.Behavioral sciences (Basel, Switzerland) · 2025Article
- Dark Triad, Depression, Anhedonia and Alexithymia: The Role of Sex Differences.Behavioral sciences (Basel, Switzerland) · 2025Article
- Disaster Exposure and Insomnia Severity During 7⋅20 Flood in Henan: The Moderated Mediation Model.PsyCh journal · 2025Article
- Age and Gender Differences in Emotional and Behavioral Functioning Among Youth Referred to a Psychiatric Outpatient Clinic at a Public Hospital.Children (Basel, Switzerland) · 2025Article
- Machiavellianism and psychopathy affect sleep quality in people with affective disorders and mentally healthy individuals.Frontiers in psychology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dark Triad has been found to relate with depressive symptoms, but the underlying mechanism was rarely investigated. In the present study, we examined the mediating effect of two emotion regulation strategies (cognitive reappraisal and expressive suppression) and the moderating effect of gender and age. 709 Chinese adolescents aged 12-18 years (M = 14.54, SD = 1.70;55.3% girls) filled out the Dirty Dozen, Emotion Regulation Questionnaire and the 10-item of Center for Epidemiological Studies Depression Scale. As expected, Dark Triad was related with increased levels of depression and emotion regulation strategies acted as mediators in these associations. Suppression mediated the relationship between Machiavellianism and depression. Reappraisal and suppression mediated the link between psychopathy and depression. Reappraisal mediated the association between narcissism and depression. Besides, age moderated the effect of Machiavellianism on reappraisal, suggesting Machiavellianism had a negative impact on reappraisal for younger adolescents, but not for older adolescents. Age also moderated the effect of reappraisal on depression, indicating the negative effect of reappraisal on depression was stronger for younger adolescents than for older adolescents. These results address how Dark Triad traits affect depression via emotion regulation strategies and indicate the effectiveness of Dark Triad and emotion regulation strategies may change across age groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.